We support regulatory and legislative policies that help ensure more people can access and afford needed treatments – including individuals negatively affected by the social determinants of health, such as race, education, ethnicity, social and economic status and those living in underserved urban and rural locations.  Our key-issue advocacy focus includes safe, efficient and reliable delivery of medicines, promoting the evolution of pharmaceutical benefit design and supporting the emerging biosimilars market.

In an ever-changing healthcare landscape, we support innovative solutions that yield improvements in treatments, drug delivery and ultimately patient care – including COVID-19 therapies, cell and gene therapies, vaccines, biosimilars and the Emergency Medicine Stockpile.  We inform federal and state elected officials about our secure, efficient and innovative pharmaceutical distribution network, which enables cost effectiveness across the entire pharmaceutical supply chain and ensures greater patient access to pharmaceuticals.

We support patient access to community-based care and believe in the empowering utility of delivering patient care in the most appropriate setting and at the right time – including through telehealth.  We continue to work on strengthening the vital role community practices, veterinarians, local health systems and independent and retail pharmacies play in ensuring patients receive quality and affordable care, where and when they need it.